WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 4'1401 Infant (under 12 months) mortality rate: 222
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 262

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 53  52  52  52  52  52  47  31 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years 13  13  13  14  14  14  12 

Number of reported case

(Click for retrospective incidence data for Marshall Islands (the))
Diphtheria
Japanese encephalitis
Measles 14 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Marshall Islands (the))
Vaccine year result method % card seen                                                
BCG          97  99  98  89  49 
DTP1          97  100  99*  23 
DTP3          80  94  96  39  92 
HepB_BD          85  99  98  100 
HepB3          80  97  100  38 
Hib3          67  92  100  45 
JapEnc         
MCV          78  97  78  94  52 
MCV2          58  90  66 
PCV1          83  98  88 
PCV3          46  24  49 
Pol3          80  95  99*  36  89 
Rota1          73  46  82 
Rota_last          60  25  71 
Rubella1          78  97  78 
TT2plus          63  39  74  53 
PAB         
VAD1          36  17  76  95 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Marshall Islands (the))
BCG 97  98  99  98  95  89  49 
DTP1 97  99  99  99  99  64  97 
DTP3 80  87  94  96  95  39  92 
HepB3 80  89  97  99  97  38  10 
Hib3 67  80  92  99  92  45 
MCV 78  88  97  78  86  94  52 
PCV3 46  35  24  49 
Pol3 80  88  95  99  96  36  89 
Rota_last 60  43  25  71 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaP 2, 4, 6, 12 months; 4-6 years; Yes
DTaPHepIPV 2, 4, 6 months; Yes
DTaPHibIPV 2, 4, 6 months; Yes
HPV 11-12 years; +2, +6 months; Yes
HepB birth; 2, 6 months; Yes and adolescents
Hib 2, 4, 12 months; Yes
IPV 2, 4, 6 months; Yes
Influenza Yes risk groups
MMR 12, 15 months; Yes
MenC_conj 11-12 years;
OPV 2, 4, 6 months; 4-6 years; Yes
Pneumo_conj 2, 4, 6, 12 months; Yes
Rotavirus 2, 4, 6 months; Yes
Td Yes every 10 years
Tdap 11-12 years; Yes
VitaminA 6-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes    Yes  Yes 
What years does the MYP cover? number 2008-2012  2012-2014  2008-2012  2008-2012    2008-2012  2003-2008 
Nº of districts with microplans that include activities to raise immunization coverage number    

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR   No  Yes         

System performance

Total number of districts in country number  
Nº districts with DTP3 coverage >=80% number      
% of districts with DTP3 coverage >=80% From 0 to 100% 100  33    100      67 
Nº districts with measles (MCV1) coverage >=95% number          
% of districts with MCV1 coverage >=95% From 0 to 100% 100           

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  No  Yes    Yes  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%   100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.